Capital Research Global Investors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-466,422
| Closed | -$45.4M | – | 452 |
|
|
2021
Q2 | $45.4M | Sell |
466,422
-1,426,644
| -75% | -$139M | 0.01% | 375 |
|
|
2021
Q1 | $221M | Buy |
1,893,066
+2,279
| +0.1% | +$267K | 0.05% | 236 |
|
|
2020
Q4 | $210M | Buy |
1,890,787
+5,460
| +0.3% | +$607K | 0.05% | 240 |
|
|
2020
Q3 | $224M | Buy |
1,885,327
+188,208
| +11% | +$22.3M | 0.07% | 205 |
|
|
2020
Q2 | $192M | Hold |
1,697,119
| – | – | 0.06% | 212 |
|
|
2020
Q1 | $113M | Hold |
1,697,119
| – | – | 0.04% | 224 |
|
|
2019
Q4 | $155M | Buy |
1,697,119
+13,850
| +0.8% | +$1.26M | 0.05% | 227 |
|
|
2019
Q3 | $145M | Buy |
1,683,269
+7
| +0% | +$604 | 0.05% | 237 |
|
|
2019
Q2 | $176M | Buy |
1,683,262
+18,810
| +1% | +$1.97M | 0.06% | 217 |
|
|
2019
Q1 | $208M | Hold |
1,664,452
| – | – | 0.07% | 205 |
|
|
2018
Q4 | $188M | Hold |
1,664,452
| – | – | 0.07% | 209 |
|
|
2018
Q3 | $356M | Buy |
1,664,452
+294,200
| +21% | +$63M | 0.1% | 174 |
|
|
2018
Q2 | $383M | Buy |
1,370,252
+373,359
| +37% | +$104M | 0.1% | 165 |
|
|
2018
Q1 | $116M | Buy |
+996,893
| New | +$116M | 0.03% | 284 |
|